Performant Healthcare downgraded to Neutral from Buy at B. Riley
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 04 2025
0mins
Should l Buy ?
Downgrade and Acquisition Details: B. Riley downgraded Performant Healthcare from Buy to Neutral, raising the price target to $7.75 following its acquisition agreement with Machinify for $670M, or $7.75 per share.
Board Approval and Timeline: The acquisition deal was unanimously approved by Performant's board and is anticipated to close by the end of 2025.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
